Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
MIRA制药早前报告:将在2024年10月28-29日于波士顿举行的第18届疼痛治疗峰会上展示新的临床前数据,显示Ketamir-2对神经病性疼痛的100%逆转。
Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
此前报道:MIRA Pharmicals将于2024年10月28日至29日在波士顿举行的第18届年度疼痛疗法峰会上公布新的临床前数据,显示Ketamir-2的神经病理性疼痛可100%逆转